Dalibor Sames
Faculty at Columbia University in the City of New York
2019Co-founder· Gilgamesh Pharmaceuticals
Founder · since 2019Company
Gilgamesh Pharmaceuticals
Role
Co-Founder
current
Stage
—
no public source
Raised
—
no public source
Based
—
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work historyProfile coverage4 of 7 · missing education, posts, contact
Gilgamesh Pharmaceuticals
Gilgamesh Pharmaceuticals, a Clinical stage biotechnology company…
Experience
Career

Columbia University in the City of New York
Faculty
2019Gilgamesh Pharmaceuticals
Co-founderCo-Founder · 2019 – Present
Bio
Professor of Chemistry at Columbia University with expertise in synthetic chemistry, medicinal chemistry, molecular design, synaptic imaging, neuropharmacology, and experimental therapeutics. Led new conceptual advances in chemical synthesis (C-H bond functionalization), developed fluorescent false neurotransmitters (FFNs), elucidated the mechanism of action of antidepressant tianeptine, expertise in iboga alkaloid and mitragynines chemistry and pharmacology.